['atopic dermatitis']
['pac-14028 cream 0.1%', 'pac-14028 cream 0.3%', 'pac-14028 cream 1.0%', 'pac-14028 cream vehicle']

        Inclusion Criteria:

          -  Male and female patients aged 19 - 70 years.

          -  Who was diagnosed with Atopic Dermatitis according to Haniffin and Rajka criteria.

          -  Whose affected BSA is over 5% and IGA score is 2 (mild) to 3 (moderate).

          -  Who voluntarily agreed to participate in the study and signed an informed consent
             form.

        Exclusion Criteria:

          -  Who has skin diseases other than atopic dermatitis or scar in the affected area which
             can affect the study, determined by the study investigators.

          -  Who has clinically significant medical history or diseases involving liver, kidney,
             neurological system, psychical disorder that can affect study results.

          -  Who has used systemic steroids, antibiotics, immunosuppressants, or received
             photochemical therapy within 28 days before study drug administration.

          -  Who has used topical steroids, immunosuppressants or antibiotics to treat atopic
             dermatitis within 14 days before study drug administration.

          -  Who has used or is expected to inevitably use prohibited concomitant medications
             during the study.

          -  Women who is pregnant /breast-feeding, or who has childbearing potential and does not
             use available contraceptives.

          -  Who has dosed other study medications within 30 days before screening.

          -  Who is determined ineligible for study participation by investigators for any other
             reasons.
      